UNSPSC 85251701: Diagnosis of malignant neoplasm on the nasal cavity

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Nasal cavity. Malignant neoplasm on the Nasal cavity is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C30. 0

UNSPSC 85251701 Diagnosis of malignant neoplasm on the nasal cavity is a Commodity code, but recent state and local opportunities show no procurement activity directly aligned with diagnostic pathology or oncology services under this code. The source contains three recent solicitations tagged to this code: a San Mateo Medical Center RFP for a Diagnostic Imaging PACS (Picture Archiving and Communication System) posted October 7, 2026 with a response due October 21, 2026; a Birdville Independent School District (BISD) RFP for special education contracted services posted September 18, 2026 with responses due October 21, 2026; and a Santa Clara County Health System qualification request for temporary health professional staffing posted July 7, 2026 with responses due October 7, 2026. None of these solicitations directly procures diagnosis of malignant neoplasm services or related oncology pathology work. The PACS opportunity concerns imaging infrastructure and data migration, not diagnostic pathology interpretation; the school district solicitation covers educational and therapeutic services wholly unrelated to oncology; and the Santa Clara Health System's temporary staffing pool includes audiology, cardiology, radiology, gastroenterology, and therapy services but does not name oncology pathology or malignant neoplasm diagnosis as a category.

The mismatch between the code's nominal scope and the actual work being solicited suggests that this code does not see relevant recent state and local procurement activity. The issuing bodies represented—a county health system, an independent school district, and a county medical center—would be typical purchasers of specialized diagnostic services, yet none has posted an opportunity for malignant neoplasm diagnosis, oncology pathology services, or related specimen analysis under this code. Without supporting evidence of active procurement demand, this code shows little current pursuit opportunity in the state and local marketplace.